3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.
about
Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivityTowards understanding the roles of heparan sulfate proteoglycans in Alzheimer's diseaseA chemokine self-presentation mechanism involving formation of endothelial surface microstructuresNovel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.Characterization of anticoagulant heparinoids by immunoprofiling.Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.Heparan sulfate 3-O-sulfation: a rare modification in search of a function.Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer3-O-sulfated heparan sulfate recognized by the antibody HS4C3 contributes [corrected] to the differentiation of mouse embryonic stem cells via fas signalingThe heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation.Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices.Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancer.Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfationExpanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entryThe glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.Direct visualization of specifically modified extracellular glycans in living animals.Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implicationsNeuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility.Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.Proteoglycanomics: tools to unravel the biological function of glycosaminoglycans.Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epitheliumN-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance.The role of heparanase and the endothelial glycocalyx in the development of proteinuria.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Glycosaminoglycans as regulators of stem cell differentiation.Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas.HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection.Extracellular sugar modifications provide instructive and cell-specific information for axon-guidance choicesRole of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation.Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities
P2860
Q24631177-F7FD530C-C412-466A-B173-91619F73074FQ26992202-AE462EC3-983B-4138-A0AE-537F15C099D4Q30540297-68CD40BA-E9E0-45C2-A4CC-08B3F12E0EE8Q33268875-96C6D3AE-7F83-423F-8EC9-1EF9ED9EDDEDQ33285352-F05AEC7A-E699-4560-9F16-61A553E93AE0Q33376879-B64B6084-7F39-49F8-86FB-B4AF85831B26Q33581865-4F5634B6-B6F2-483D-87EA-BB5789FECBDBQ33690545-365E7F8D-100A-427F-947D-D107B15110ABQ33803148-7F15B491-E498-4BBD-9052-C002A470F979Q34391600-55FBB3B0-F14F-425D-BAD8-3223BAAB9B68Q34412830-76B629D2-7F75-4204-9C0F-B418E79628F0Q34509764-A1646E13-BEEF-4E67-80BA-D9D5EED226EAQ34757062-2F3B1732-AFFA-455E-A06F-2DAE1202E5DCQ34774580-8E9A07ED-FEB8-45D5-AA54-C1DBA5C80E33Q35073707-1AC34444-27EF-4467-BE2E-6DB80695963CQ35221119-85CCD91B-E685-4B61-82B5-3A19D3FBA4C2Q35224992-92C463AA-5B53-4375-A4E2-39CF6CF1D52EQ35879491-7944ABF7-10C8-4258-8FBD-DD4C1F83AF37Q35955720-C4AC21E8-E326-4DC7-B08E-802C9CE8D39FQ35955763-5DC06ECC-C8B4-4596-9294-254BF53D7976Q36007478-1BFF48EC-42B2-472B-AD78-A0A5C2AF19E3Q36222320-15275BF6-8C3E-41AF-9E9A-3A880919672CQ36253322-CD76C820-0FC1-423F-A82C-D684933A62B7Q36547314-1BCE129D-908C-4646-AD45-6F6ED1979C10Q36721742-00DB4BD4-64A3-4537-ACEF-A285DB0A6E3EQ36892524-8D292A12-F1E7-4FE2-8AF5-88ABF7E1DD77Q36906823-A16AE963-AC03-451A-A7C8-301D4CD9C1A6Q36942414-1CCA42DB-F53A-49B4-A3E2-3F7E410B4923Q37211809-D04396BE-2B5A-4279-9EFD-58BABD833F44Q37335962-B4EDD994-A86D-4B84-8255-4492C20E74C5Q37354141-0BA9FD4B-D0A6-49E3-A72F-C711EA6AF810Q38156098-EF9C21A0-B60E-4729-BEEB-B07C031F7138Q39060517-B0FE491B-097F-4A88-9D4D-796AB048A43AQ39603105-AE13DCF2-62F5-40FC-A24F-2F1EDCA2AFE9Q39861917-1229405B-D7BF-4F32-8BEC-E85B43070686Q40281690-0B9F57C9-B85E-4916-BC39-C6B3A2F51EDCQ42047138-DAFFA96D-4BAC-45D0-AD2E-48564F0CC6F9Q42121097-B5DBDDD3-DDB7-49C6-B30E-2551DC2020EBQ42276166-ADCCECD7-03E2-40CD-B4A0-44153C89C541Q42276329-B582850F-08E9-4A0A-B571-46CB3BD40D2C
P2860
3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@ast
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@en
type
label
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@ast
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@en
prefLabel
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@ast
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@en
P2093
P2860
P356
P1476
3-O-sulfated oligosaccharide s ...... eparan sulfate antibody HS4C3.
@en
P2093
Elly M M Versteeg
Els M A van de Westerlo
Gerdy B Ten Dam
Sindhulakshmi Kurup
Toin H van Kuppevelt
P2860
P304
P356
10.1074/JBC.M506357200
P407
P577
2005-12-22T00:00:00Z